Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 16 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

16 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
May 16, 2025 SURG P 15,073 $2.75 $41,451 5,785,163 Direct +0.26% Acquired -94.7% (price as of 2026-10-02)
Dec. 3, 2024 SURG S 35,180 $1.82 $64,028 5,770,090 Direct -0.61% Disposed -91.9% (price as of 2026-10-02)
Nov. 4, 2024 SURG S 31,700 $1.60 $50,720 5,805,270 Direct -0.54% Disposed -90.8% (price as of 2026-10-02)
Oct. 2, 2024 SURG S 32,375 $1.75 $56,656 5,836,970 Direct -0.55% Disposed -91.6% (price as of 2026-10-02)
Sept. 3, 2024 SURG S 35,100 $1.48 $51,948 5,786,012 Direct -0.60% Disposed -90.1% (price as of 2026-10-02)
Aug. 2, 2024 SURG S 33,600 $2.60 $87,360 5,737,779 Direct -0.58% Disposed -94.4% (price as of 2026-10-02)
July 2, 2024 SURG S 20,915 $3.05 $63,791 5,688,046 Direct -0.37% Disposed -95.2% (price as of 2026-10-02)
Aug. 15, 2023 SURG P 5,200 $4.72 $24,544 4,507,894 Direct +0.12% Acquired -96.9% (price as of 2026-10-02)
Aug. 31, 2022 SURG P 5,000 $4.30 $21,500 3,452,694 Direct +0.15% Acquired -96.6% (price as of 2026-10-02)
Aug. 18, 2022 SURG P 5,000 $4.78 $23,900 3,447,694 Direct +0.15% Acquired -96.9% (price as of 2026-10-02)
Aug. 18, 2022 SURG P 2,000 $4.73 $9,460 3,449,694 Direct +0.06% Acquired -96.9% (price as of 2026-10-02)
June 2, 2022 SURG P 4,900 $4.39 $21,511 3,442,694 Direct +0.14% Acquired -96.7% (price as of 2026-10-02)
Sept. 9, 2021 SURG P 500,000 $0.10 $50,000 21,048,724 Direct +2.43% Acquired -97.1% (price as of 2026-10-02)
Feb. 24, 2021 SURG P 120,000 $0.16 $19,200 20,548,724 Direct +0.59% Acquired -98.2% (price as of 2026-10-02)
Jan. 7, 2021 SURG P 21,298 $0.11 $2,343 20,450,022 Direct +0.10% Acquired -97.3% (price as of 2026-10-02)
Dec. 28, 2020 SURG P 120,000 $0.15 $18,000 20,428,724 Direct +0.59% Acquired -98.0% (price as of 2026-10-02)
Dec. 4, 2020 SURG P 100,000 $0.15 $15,000 20,308,724 Direct +0.49% Acquired -98.0% (price as of 2026-10-02)
Nov. 10, 2020 SURG P 162,054 $0.12 $19,446 20,208,724 Direct +0.81% Acquired -97.6% (price as of 2026-10-02)
Nov. 5, 2020 SURG P 87,500 $0.08 $7,000 20,046,670 Direct +0.44% Acquired -96.3% (price as of 2026-10-02)
Nov. 4, 2020 SURG P 157,559 $0.08 $12,605 19,959,170 Direct +0.80% Acquired -96.3% (price as of 2026-10-02)
Oct. 28, 2020 SURG P 4,900 $0.09 $441 19,801,611 Direct +0.02% Acquired -96.7% (price as of 2026-10-02)
Oct. 27, 2020 SURG P 250,000 $0.10 $25,000 19,796,711 Direct +1.28% Acquired -97.1% (price as of 2026-10-02)
Oct. 22, 2020 SURG P 126,800 $0.10 $12,680 19,546,711 Direct +0.65% Acquired -97.1% (price as of 2026-10-02)
Oct. 16, 2020 SURG P 5,625 $0.11 $619 19,419,911 Direct +0.03% Acquired -97.3% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Dec. 28, 2022 SURG Series A Preferred Stock Common Stock (1,050,000) $0.00 · 10,500,000 Disposed
Nov. 11, 2021 SURG Series C Preferred Common Stock (3,016,820) · · 603,364 Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 6 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Oct. 9, 2020 SURG Common stock, $0.001 par value per share 19,414,286 Direct
Oct. 9, 2020 SURG Common stock, $0.001 par value per share 4,813,885 Indirect
Oct. 9, 2020 SURG Common stock, $0.001 par value per share 1,800,000 Indirect
Oct. 9, 2020 SURG Series A Preferred→ Common Stock (10,425,000) 10,425,000 Direct
Oct. 9, 2020 SURG Series A Preferred→ Common Stock (75,000) 75,000 Indirect
Oct. 9, 2020 SURG Series C Preferred→ Common Stock (603,364) 603,364 Direct